UiPath, Inc. (NYSE:PATH) Receives Consensus Rating of "Hold" from Brokerages

Key Points

• UiPath, Inc. has received a consensus rating of "Hold" from eighteen brokerages, with three recommending sell, twelve hold, two buy, and one strong buy.
• The company's quarterly earnings beat estimates with reported EPS of $0.15, exceeding the consensus estimate of $0.08, and revenue was up 14.6% year-over-year.
• CEO Daniel Dines and another insider recently sold significant shares of UiPath, indicating a 20% decrease in ownership for the CEO and a continued selling trend among insiders.

Shares of UiPath, Inc. (NYSE:PATH - Get Free Report) have received an average rating of "Hold" from the eighteen brokerages that are covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a sell recommendation, twelve have issued a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $13.2143.

A number of research firms have issued reports on PATH. Cowen reiterated a "hold" rating on shares of UiPath in a report on Friday, September 5th. DA Davidson started coverage on UiPath in a research note on Friday, September 5th. They issued a "neutral" rating and a $12.00 target price on the stock. Wall Street Zen raised UiPath from a "buy" rating to a "strong-buy" rating in a research note on Saturday, September 6th. Weiss Ratings reissued a "sell (d)" rating on shares of UiPath in a research note on Wednesday. Finally, Canaccord Genuity Group cut their target price on UiPath from $16.00 to $15.00 and set a "buy" rating on the stock in a research note on Monday, September 8th.

UiPath Trading Down 8.0%

PATH opened at $17.04 on Friday. The stock has a fifty day simple moving average of $11.99 and a two-hundred day simple moving average of $12.02. The company has a market cap of $9.05 billion, a price-to-earnings ratio of 567.83, a price-to-earnings-growth ratio of 6.85 and a beta of 1.07. UiPath has a 12-month low of $9.38 and a 12-month high of $18.74.

UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings data on Thursday, September 4th. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.08 by $0.07. The business had revenue of $361.73 million during the quarter, compared to the consensus estimate of $347.36 million. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The firm's quarterly revenue was up 14.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.04 earnings per share. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. On average, analysts predict that UiPath will post -0.17 EPS for the current year.

Insiders Place Their Bets

In related news, CEO Daniel Dines sold 122,734 shares of the stock in a transaction on Friday, October 10th. The stock was sold at an average price of $18.37, for a total transaction of $2,254,623.58. Following the sale, the chief executive officer directly owned 490,936 shares of the company's stock, valued at $9,018,494.32. This trade represents a 20.00% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Brad Brubaker sold 66,665 shares of the stock in a transaction on Monday, October 6th. The shares were sold at an average price of $15.00, for a total value of $999,975.00. Following the sale, the insider directly owned 690,519 shares in the company, valued at $10,357,785. This trade represents a 8.80% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,770,068 shares of company stock worth $23,301,992. Insiders own 23.19% of the company's stock.

Institutional Investors Weigh In On UiPath

Several institutional investors have recently modified their holdings of PATH. GAMMA Investing LLC boosted its position in shares of UiPath by 1,207.7% during the first quarter. GAMMA Investing LLC now owns 20,806 shares of the company's stock valued at $2,020,000 after buying an additional 19,215 shares during the last quarter. CX Institutional purchased a new stake in shares of UiPath during the first quarter valued at $36,000. Fort Washington Investment Advisors Inc. OH boosted its position in UiPath by 100.0% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 85,290 shares of the company's stock worth $878,000 after purchasing an additional 42,645 shares during the last quarter. NorthCrest Asset Manangement LLC boosted its position in UiPath by 87.8% in the first quarter. NorthCrest Asset Manangement LLC now owns 20,929 shares of the company's stock worth $216,000 after purchasing an additional 9,782 shares during the last quarter. Finally, Stanley Laman Group Ltd. boosted its position in UiPath by 111.8% in the first quarter. Stanley Laman Group Ltd. now owns 736,960 shares of the company's stock worth $7,591,000 after purchasing an additional 388,971 shares during the last quarter. 62.50% of the stock is owned by hedge funds and other institutional investors.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.